Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06091969 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Supplementation for Male Subfertility

Study acronym: FertEnhancer
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 10, 2024 (before its estimated February 2, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Feb 2, 2025 to Feb 2, 2026
    • Start date: Feb 2, 2024 to Jan 1, 2025
    • Eligibility criteria expanded, about 16 words
    • Study description expanded, about 30 words
    v4
  2. Primary endpoints: 4 to 6
    • Secondary endpoints: details revised at 18 of 19 entries
    • Study description expanded, about 28 words
    v3
  3. Secondary endpoints revised (19)
    • Study description expanded, about 19 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Old age, obesity, physical inactivity, environmental factors and genetics may contribute negatively to fertility in both males and females. In males, specifically, certain supplements, such as single antioxidants and trace minerals, have previously been shown to improve sperm function marginally. One hypothesis is that sperm function can be improved even further by combining several different types of supplements (e.g., amino acids, energy carriers, vitamins, antioxidants, and trace minerals) to target several age-related cell pathways, for example, oxidative stress, mitochondrial dysfunction, inflammation and cell energetics. This 3-month placebo-controlled, randomized clinical trial, aims to test the effects of a novel multi-ingredient supplement (Fertility Enhancer) that targets several age-related cell pathways on sperm function in overweight or obese and subfertile males.
Trial Details
NCT Number NCT06091969
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: One Fertility
Conditions
(from sponsor)		 Male Infertility
Related terms Infertility, Infertility, Male, Inflammation, Obesity, Weight Loss
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov